Wei Wan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Wei Wan has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
Qian Wang
Department of Thoracic Surgery of Sir Run Run Shaw Hospital, and Department of Biochemistry, Zhejiang University School of Medicine, Hangzhou, China
7 shared publications- Wei Liu
Center for Metabolism Research, The Fourth Affiliated Hospital of Zhejiang University School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University 1 Department of Respiratory and Critical Care Medicine Yiwu
7 shared publications Yinfeng Xu
Laboratory of Basic Biology, Hunan First Normal University, Changsha, Hunan, China
7 shared publicationsChuying Qian
Department of Thoracic Surgery of Sir Run Run Shaw Hospital, and Department of Biochemistry, Zhejiang University School of Medicine, Hangzhou, China
6 shared publications- Yinfeng Xu
Hunan First Normal University
6 shared publications - Jianru Xiao
Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China
5 shared publications
Latest Publications
- 18 October 2026
- Published by Taylor & Francis in Autophagy
- p. 1-15
TBK1-mediated phosphorylation of WIPI2 links bacteria recognition to autophagosome formation in xenophagy
Macroautophagy/autophagy is an evolutionarily conserved cellular process in which cytoplasmic materials are sequestered within double-membrane autophagosomes and degraded upon fusion with lysosomes...
- 18 October 2026
- Published by Taylor & Francis in Autophagy
- p. 1-15
TBK1-mediated phosphorylation of WIPI2 links bacteria recognition to autophagosome formation in xenophagy
Macroautophagy/autophagy is an evolutionarily conserved cellular process in which cytoplasmic materials are sequestered within double-membrane autophagosomes and degraded upon fusion with lysosomes...
- Open Access
- 29 May 2026
- Published by Science China Press., Co. Ltd. in SCIENTIA SINICA Vitae
- Vol. 56 (6) , 1338-1346
Regulation and function of TFEB in the immune responses
转录因子TFEB(transcription factor EB)及其同家族蛋白TFE3(transcription factor E3)和MITF(microphthalmia-associated transcription factor)是哺乳动物细胞内在转录水平调控自噬(autophagy)和溶酶体(lysosome)生物发生的关键分子。营养感受器蛋白激酶mTORC1(mechanistic target of rapamycin complex 1)通过控制TFEB的亚细胞定位调控其转录活性,将细胞的营养状态与TFEB的活性关联起来。近年发现,TFEB的活性也受到多种不同的免疫信号的调控。免疫信号通过提高TFEB活性,启动自噬和溶酶体生物发生,进而促进细胞清除入侵的病毒和细菌。与此同时,自噬和溶酶体系统也可反过来通过降解多种不同的免疫信号分子,限制过度的免疫反应,从而避免造成自身细胞的损伤或死亡。有趣的是,在某些特定应激条件下,TFEB也可直接激活某些炎性细胞因子的表达,上调细胞和机体的免疫反应,进而促进入侵细菌的清除。这些研究成果表明,TFEB可作为多种不同的免疫信号共同的效应蛋白,通过多种作用机制在细胞和机体的免疫反应中行使重要功能。本文将围绕免疫信号调控TFEB活性的机制和功能综述近年来的相关研究进展。
- 29 May 2026
- Published by Science China Press., Co. Ltd. in SCIENTIA SINICA Vitae
- Vol. 56 (6) , 1338-1346
Open AccessRegulation and function of TFEB in the immune responses
转录因子TFEB(transcription factor EB)及其同家族蛋白TFE3(transcription factor E3)和MITF(microphthalmia-associated transcription factor)是哺乳动物细胞内在转录水平调控自噬(autophagy)和溶酶体(lysosome)生物发生的关键分子。营养感受器蛋白激酶mTORC1(mechanistic target of rapamycin complex 1)通过控制TFEB的亚细胞定位调控其转录活性,将细胞的营养状态与TFEB的活性关联起来。近年发现,TFEB的活性也受到多种不同的免疫信号的调控。免疫信号通过提高TFEB活性,启动自噬和溶酶体生物发生,进而促进细胞清除入侵的病毒和细菌。与此同时,自噬和溶酶体系统也可反过来通过降解多种不同的免疫信号分子,限制过度的免疫反应,从而避免造成自身细胞的损伤或死亡。有趣的是,在某些特定应激条件下,TFEB也可直接激活某些炎性细胞因子的表达,上调细胞和机体的免疫反应,进而促进入侵细菌的清除。这些研究成果表明,TFEB可作为多种不同的免疫信号共同的效应蛋白,通过多种作用机制在细胞和机体的免疫反应中行使重要功能。本文将围绕免疫信号调控TFEB活性的机制和功能综述近年来的相关研究进展。
- 26 May 2026
- Published by Taylor & Francis in Autophagy
- Vol. 22 (11) , 3351-3353
Cytosolic DNA as an inhibitor of rDNA transcription
CGAMP: cyclic GMP-AMP; CGAS: cyclic GMP-AMP synthase; HSV-1: herpes simplex virus-1; POLR1A: RNA polymerase I subunit A; rDNA: ribosomal DNA; rRNA: ribosomal RNA; SQSTM1: sequestosome 1; STING1: st...
- 26 May 2026
- Published by Taylor & Francis in Autophagy
- Vol. 22 (11) , 3351-3353
Cytosolic DNA as an inhibitor of rDNA transcription
CGAMP: cyclic GMP-AMP; CGAS: cyclic GMP-AMP synthase; HSV-1: herpes simplex virus-1; POLR1A: RNA polymerase I subunit A; rDNA: ribosomal DNA; rRNA: ribosomal RNA; SQSTM1: sequestosome 1; STING1: st...
- Open Access
- 5 May 2026
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (12) , 4153-4175
Cytosolic DNA inhibits rDNA transcription by retaining the RNA polymerase I transcription machinery
Cytosolic DNA, derived from cellular damage or microbial infection, functions as a pivotal trigger for the host innate immune responses by activating intracellular DNA-sensing machinery, including the cGAS-STING pathway. However, whether cytosolic DNA is involved in DNA-sensing pathway-independent biological processes remains largely unknown. Here, we show that cytosolic DNA interacts with UBTF and POLR1A, two essential components of the RNA polymerase I transcription machinery, and sequesters these two proteins in the cytoplasm. This retention decreases nuclear UBTF and POLR1A, inhibits rDNA transcription, suppresses protein synthesis, and curtails cell proliferation. Furthermore, we demonstrate that STING-induced autophagy specifically eliminates cytosolic DNA and restores nuclear UBTF and POLR1A, thereby abolishing the inhibitory effects of cytosolic DNA on rDNA transcription, protein synthesis, and cell proliferation. Thus, our findings uncover a novel role of cytosolic DNA in rDNA transcription, suggesting that cytosolic DNA not only activates immune responses but also interferes with cell metabolism.
- 5 May 2026
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (12) , 4153-4175
Open AccessCytosolic DNA inhibits rDNA transcription by retaining the RNA polymerase I transcription machinery
Cytosolic DNA, derived from cellular damage or microbial infection, functions as a pivotal trigger for the host innate immune responses by activating intracellular DNA-sensing machinery, including the cGAS-STING pathway. However, whether cytosolic DNA is involved in DNA-sensing pathway-independent biological processes remains largely unknown. Here, we show that cytosolic DNA interacts with UBTF and POLR1A, two essential components of the RNA polymerase I transcription machinery, and sequesters these two proteins in the cytoplasm. This retention decreases nuclear UBTF and POLR1A, inhibits rDNA transcription, suppresses protein synthesis, and curtails cell proliferation. Furthermore, we demonstrate that STING-induced autophagy specifically eliminates cytosolic DNA and restores nuclear UBTF and POLR1A, thereby abolishing the inhibitory effects of cytosolic DNA on rDNA transcription, protein synthesis, and cell proliferation. Thus, our findings uncover a novel role of cytosolic DNA in rDNA transcription, suggesting that cytosolic DNA not only activates immune responses but also interferes with cell metabolism.
- 24 September 2025
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 50 (11) , 956-959
The interplay of the cGAS–STING pathway with the lysosome
- 24 September 2025
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 50 (11) , 956-959
The interplay of the cGAS–STING pathway with the lysosome
- 28 August 2025
- Published by Taylor & Francis in Autophagy
- Vol. 21 (12) , 2948-2962
Deacetylation of ATG16L1 is required for LC3-associated lysosomal microautophagy
Microautophagy is a selective cellular process in which endolysosomes directly engulf cytoplasmic cargo through membrane invagination. The regulatory mechanisms governing microautophagy remain poorly understood. Here, we identified the deacetylation of ATG16L1 as a critical regulator of LC3-associated lysosomal microautophagy. We demonstrate that ATG16L1 acetylation is dynamically controlled by the acetyltransferase KAT2B and the deacetylase HDAC3. Under lysosomal osmotic stress or glucose deprivation, HDAC3-mediated deacetylation of ATG16L1 within its WD40 domain promotes its interaction with V-ATPase, facilitating ATG16L1 recruitment to lysosomal membranes. While dispensable for macroautophagy, this post-translational modification is essential for LC3 lipidation on lysosomes and enables lysosomal recovery, including the restoration of lysosomal size and degradative capacity following stress. Our results reveal a key role for ATG16L1 deacetylation in driving LC3-associated microautophagy to maintain lysosomal homeostasis.
- 28 August 2025
- Published by Taylor & Francis in Autophagy
- Vol. 21 (12) , 2948-2962
Deacetylation of ATG16L1 is required for LC3-associated lysosomal microautophagy
Microautophagy is a selective cellular process in which endolysosomes directly engulf cytoplasmic cargo through membrane invagination. The regulatory mechanisms governing microautophagy remain poorly understood. Here, we identified the deacetylation of ATG16L1 as a critical regulator of LC3-associated lysosomal microautophagy. We demonstrate that ATG16L1 acetylation is dynamically controlled by the acetyltransferase KAT2B and the deacetylase HDAC3. Under lysosomal osmotic stress or glucose deprivation, HDAC3-mediated deacetylation of ATG16L1 within its WD40 domain promotes its interaction with V-ATPase, facilitating ATG16L1 recruitment to lysosomal membranes. While dispensable for macroautophagy, this post-translational modification is essential for LC3 lipidation on lysosomes and enables lysosomal recovery, including the restoration of lysosomal size and degradative capacity following stress. Our results reveal a key role for ATG16L1 deacetylation in driving LC3-associated microautophagy to maintain lysosomal homeostasis.
- Open Access
- 24 February 2025
- Published by Springer Nature in Bone Research
- Vol. 13 (1) , 1-13
Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma
Osteosarcoma (OS) is the most prevalent type of primary malignant bone cancer and currently lacks effective targeted treatments. Increasing evidence indicates that SOX2 overexpression is a primary driver of OS. By screening a small-molecule kinase inhibitor library, we identified AKT as a kinase essential for robust SOX2 expression in OS cells. AKT was found to be frequently overexpressed in OS and positively correlated with SOX2 protein levels. We demonstrated that AKT has no effect on SOX2 transcription but promotes SOX2 protein stability. Mechanistically, AKT binds to and phosphorylates SOX2 at T116, preventing SOX2 ubiquitination and proteasome-dependent degradation by ubiquitin E3 ligases UBR5 and STUB1. Moreover, we found that AKT-SOX2 axis is a significant modulator of cancer stemness and chemoresistance and that the combination of AKT inhibitor MK2206 and cisplatin resulted in a synergistic and potent inhibition of OS tumor growth in the PDX model. In conclusion, we identified a critical role for AKT in promoting SOX2 overexpression, tumor stemness, and chemoresistance in OS, and provided evidence that targeting AKT combined with chemotherapy may hold promise for treating refractory OS.
- 24 February 2025
- Published by Springer Nature in Bone Research
- Vol. 13 (1) , 1-13
Open AccessTargeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma
Osteosarcoma (OS) is the most prevalent type of primary malignant bone cancer and currently lacks effective targeted treatments. Increasing evidence indicates that SOX2 overexpression is a primary driver of OS. By screening a small-molecule kinase inhibitor library, we identified AKT as a kinase essential for robust SOX2 expression in OS cells. AKT was found to be frequently overexpressed in OS and positively correlated with SOX2 protein levels. We demonstrated that AKT has no effect on SOX2 transcription but promotes SOX2 protein stability. Mechanistically, AKT binds to and phosphorylates SOX2 at T116, preventing SOX2 ubiquitination and proteasome-dependent degradation by ubiquitin E3 ligases UBR5 and STUB1. Moreover, we found that AKT-SOX2 axis is a significant modulator of cancer stemness and chemoresistance and that the combination of AKT inhibitor MK2206 and cisplatin resulted in a synergistic and potent inhibition of OS tumor growth in the PDX model. In conclusion, we identified a critical role for AKT in promoting SOX2 overexpression, tumor stemness, and chemoresistance in OS, and provided evidence that targeting AKT combined with chemotherapy may hold promise for treating refractory OS.
- 27 January 2025
- Published by Taylor & Francis in Autophagy
- Vol. 21 (5) , 1163-1164
Induction of lysosome biogenesis is a novel function of the CGAS-STING1 pathway
Induction of macroautophagy/autophagy has been established as an important function elicited by the CGAS-STING1 pathway during pathogen infection. However, it remains unknown whether lysosomal activity within the cell in these settings is concurrently enhanced to cope with the increased autophagic flux. Recently, we discovered that the CGAS-STING1 pathway elevates the degradative capacity of the cell by activating lysosome biogenesis. Intriguingly, we found that STING1-induced GABARAP lipidation, rather than TBK1 activation, serves as the key mediator triggering the nuclear translocation of transcription factor TFEB and enhances the expression of lysosome-related genes. Mechanistically, we demonstrated that lipidated GABARAP on single membranes, regulated by the V-ATPase-ATG16L1 axis, sequesters the FLCN-FNIP complex to abolish its function toward RRAGC-RRAGD, leading to a specific impairment of MTORC1-dependent phosphorylation of TFEB and resulting in its subsequent nuclear translocation. Functionally, we showed that STING1-induced lysosome biogenesis is essential for the clearance of cytoplasmic DNA and the elimination of invading pathogens. Collectively, our findings underscore the induction of lysosome biogenesis as a novel function of the CGAS-STING1 pathway.China; Yinfeng Xu; Email: yinfengxu@hnfnu.edu.cn; Hunan First Normal University, 1015 Feng-Lin-San Road, Changsha, Hunan 410,205, China.
- 27 January 2025
- Published by Taylor & Francis in Autophagy
- Vol. 21 (5) , 1163-1164
Induction of lysosome biogenesis is a novel function of the CGAS-STING1 pathway
Induction of macroautophagy/autophagy has been established as an important function elicited by the CGAS-STING1 pathway during pathogen infection. However, it remains unknown whether lysosomal activity within the cell in these settings is concurrently enhanced to cope with the increased autophagic flux. Recently, we discovered that the CGAS-STING1 pathway elevates the degradative capacity of the cell by activating lysosome biogenesis. Intriguingly, we found that STING1-induced GABARAP lipidation, rather than TBK1 activation, serves as the key mediator triggering the nuclear translocation of transcription factor TFEB and enhances the expression of lysosome-related genes. Mechanistically, we demonstrated that lipidated GABARAP on single membranes, regulated by the V-ATPase-ATG16L1 axis, sequesters the FLCN-FNIP complex to abolish its function toward RRAGC-RRAGD, leading to a specific impairment of MTORC1-dependent phosphorylation of TFEB and resulting in its subsequent nuclear translocation. Functionally, we showed that STING1-induced lysosome biogenesis is essential for the clearance of cytoplasmic DNA and the elimination of invading pathogens. Collectively, our findings underscore the induction of lysosome biogenesis as a novel function of the CGAS-STING1 pathway.China; Yinfeng Xu; Email: yinfengxu@hnfnu.edu.cn; Hunan First Normal University, 1015 Feng-Lin-San Road, Changsha, Hunan 410,205, China.
- Top Cited Papers
The cGAS-STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearance
- Open Access
- 14 November 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (11) , 1455
Development of a Graphene Oxide-Based Aptamer Nanoarray for Improved Neutralization and Protection Effects Against Ricin
Background/Objectives: Ricin’s high toxicity and potential as a bioweapon underscore the need for effective antidotes. Monoclonal antibodies, though effective, are limited by complex production. This study aimed to develop a graphene oxide-based aptamer nanoarray (ARMAN) for improved neutralization and protection against ricin. Methods: High-affinity aptamers targeting ricin’s RTA and RTB subunits were selected using SELEX technology and conjugated to graphene oxide (GO) via click chemistry. ARMAN’s characteristics, including morphology, stability, and biosecurity, were assessed. Its performance was evaluated in terms of affinity for ricin, neutralization capacity, and therapeutic effects in cellular assays and a mouse model of ricin poisoning. Results: ARMAN exhibited a uniform morphology with an average particle size of 217 nm and demonstrated significantly enhanced affinity for ricin compared to free aptamers. ARMAN showed rapid and effective neutralization ability, significantly increasing cell viability in BEAS-2B, GES-1, and HL7702 cell lines exposed to ricin. In vivo, ARMAN treatment led to a notable prolongation of survival in ricin-poisoned mice, highlighting its potential for both pre- and post-exposure treatment. These findings indicate that ARMAN not only neutralizes ricin effectively but also provides a therapeutic window for treatment. Conclusions: ARMAN’s superior binding affinity, serum stability, biocompatibility, and broad therapeutic efficacy make it a promising new antidote against ricin poisoning. This study’s findings represent significant progress in the development of rapid-response antidotes, with ARMAN offering a potential solution for both military and civilian emergency response scenarios.
- 14 November 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (11) , 1455
Open AccessDevelopment of a Graphene Oxide-Based Aptamer Nanoarray for Improved Neutralization and Protection Effects Against Ricin
Background/Objectives: Ricin’s high toxicity and potential as a bioweapon underscore the need for effective antidotes. Monoclonal antibodies, though effective, are limited by complex production. This study aimed to develop a graphene oxide-based aptamer nanoarray (ARMAN) for improved neutralization and protection against ricin. Methods: High-affinity aptamers targeting ricin’s RTA and RTB subunits were selected using SELEX technology and conjugated to graphene oxide (GO) via click chemistry. ARMAN’s characteristics, including morphology, stability, and biosecurity, were assessed. Its performance was evaluated in terms of affinity for ricin, neutralization capacity, and therapeutic effects in cellular assays and a mouse model of ricin poisoning. Results: ARMAN exhibited a uniform morphology with an average particle size of 217 nm and demonstrated significantly enhanced affinity for ricin compared to free aptamers. ARMAN showed rapid and effective neutralization ability, significantly increasing cell viability in BEAS-2B, GES-1, and HL7702 cell lines exposed to ricin. In vivo, ARMAN treatment led to a notable prolongation of survival in ricin-poisoned mice, highlighting its potential for both pre- and post-exposure treatment. These findings indicate that ARMAN not only neutralizes ricin effectively but also provides a therapeutic window for treatment. Conclusions: ARMAN’s superior binding affinity, serum stability, biocompatibility, and broad therapeutic efficacy make it a promising new antidote against ricin poisoning. This study’s findings represent significant progress in the development of rapid-response antidotes, with ARMAN offering a potential solution for both military and civilian emergency response scenarios.